POLYDERM A+B(TM)— 510(k) K880153

Name: FDA 510(k) clearance K880153
Creator: U.S. Food and Drug Administration
Published: 1988-04-13

Substantially Equivalent for Some Indications

Laivan Corp.

FDA 510(k) clearance K880153 for POLYDERM A+B(TM), Substantially Equivalent for Some Indications on 1988-04-13. Applicant: Laivan Corp.. Device class: 1.

Clearance details

Applicant: Laivan Corp.
Product code: Code NAD
Device class: Class 1
Regulation: 21 CFR 878.4020
Advisory panel: General, Plastic Surgery
Date received: 1988-01-13
Decision date: 1988-04-13
Decision: Substantially Equivalent for Some Indications
Clearance type: Traditional
Location: East Rockaway, NY, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code NAD

view all

K254246 — LT Antibacterial Foam with Silver Dressing2026-09-10
K102403 — SAM CHEST SEAL WITH VAVLE2011-03-03
K091133 — APLION TOPICAL CARE SYSTEM2009-05-20
K072560 — ENVELA (HYDROHESIVE OCCLUSIVE DRESSING)2008-06-17
K080524 — CENTURION SORBAVIEW OTC2008-04-23

More clearances from Laivan Corp.

view all

K923815 — TOTAL PROTECTIVE BREATHEABLE SURGICAL GOWNS1993-03-31
K890940 — MODIFIED LABELING FOR POLYDERM WBC(TM)1989-04-17
K885205 — AQUADERM1989-03-29
K880964 — POLYDERM PEC(TM), POROUS ELASTIC COVER1988-03-17
K880206 — POLYDERM WBC (TM), WATERPROOF BREATHABLE COVER1988-03-11

Adverse events under product code NAD

product code NAD

Injury: 431
Malfunction: 11,935
Other: 1
Total: 12,367

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.